Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study

As non-high-density lipoprotein cholesterol (non-HDL-C) levels account for all atherogenic lipoproteins, serum non-HDL-C level has been suggested to be a marker for cardiovascular (CV) risk stratification. Therefore, to unveil the association of serum non-HDL-C levels with CV outcomes in patients wi...

Full description

Bibliographic Details
Main Authors: Sang Heon Suh, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Kook-Hwan Oh, Seung Hyeok Han, Soo Wan Kim
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/14/18/3792
_version_ 1797483980374671360
author Sang Heon Suh
Tae Ryom Oh
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Kook-Hwan Oh
Seung Hyeok Han
Soo Wan Kim
author_facet Sang Heon Suh
Tae Ryom Oh
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Kook-Hwan Oh
Seung Hyeok Han
Soo Wan Kim
author_sort Sang Heon Suh
collection DOAJ
description As non-high-density lipoprotein cholesterol (non-HDL-C) levels account for all atherogenic lipoproteins, serum non-HDL-C level has been suggested to be a marker for cardiovascular (CV) risk stratification. Therefore, to unveil the association of serum non-HDL-C levels with CV outcomes in patients with non-dialysis chronic kidney disease (ND-CKD), the patients at stages 1 to 5 (<i>n</i> = 2152) from the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD) were prospectively analyzed. The subjects were divided into quintiles by serum non-HDL-C level. The primary outcome was a composite of all-cause death or non-fatal CV events. The median duration of follow-up was 6.940 years. The analysis using the Cox proportional hazard model unveiled that the composite CV event was significantly increased in the 5th quintile (adjusted hazard ratio 2.162, 95% confidence interval 1.174 to 3.981), compared to that of the 3rd quintile. A fully adjusted cubic spline model depicted a non-linear, J-shaped association between non-HDL-C and the risk of a composite CV event. The association remained robust in a series of sensitivity analyses, including the analysis of a cause-specific hazard model. Subgroup analyses reveled that the association is not significantly altered by clinical conditions, including age, gender, body mass index, estimated glomerular filtration rate, and albuminuria. In conclusion, high serum non-HDL-C level increased the risk of adverse CV outcomes among the patients with ND-CKD. Further studies are warranted to define the optimal target range of non-HDL-C levels in this population.
first_indexed 2024-03-09T22:54:54Z
format Article
id doaj.art-277a30037f31497a88ac938064369a5d
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T22:54:54Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-277a30037f31497a88ac938064369a5d2023-11-23T18:11:58ZengMDPI AGNutrients2072-66432022-09-011418379210.3390/nu14183792Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD StudySang Heon Suh0Tae Ryom Oh1Hong Sang Choi2Chang Seong Kim3Eun Hui Bae4Seong Kwon Ma5Kook-Hwan Oh6Seung Hyeok Han7Soo Wan Kim8Department of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaDepartment of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaDepartment of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaDepartment of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaDepartment of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaDepartment of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaDepartment of Internal Medicine, Seoul National University Hospital, Seoul 03080, KoreaDepartment of Internal Medicine, Institute of Kidney Disease Research, College of Medicine, Yonsei University, Seoul 03722, KoreaDepartment of Internal Medicine, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju 64169, KoreaAs non-high-density lipoprotein cholesterol (non-HDL-C) levels account for all atherogenic lipoproteins, serum non-HDL-C level has been suggested to be a marker for cardiovascular (CV) risk stratification. Therefore, to unveil the association of serum non-HDL-C levels with CV outcomes in patients with non-dialysis chronic kidney disease (ND-CKD), the patients at stages 1 to 5 (<i>n</i> = 2152) from the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD) were prospectively analyzed. The subjects were divided into quintiles by serum non-HDL-C level. The primary outcome was a composite of all-cause death or non-fatal CV events. The median duration of follow-up was 6.940 years. The analysis using the Cox proportional hazard model unveiled that the composite CV event was significantly increased in the 5th quintile (adjusted hazard ratio 2.162, 95% confidence interval 1.174 to 3.981), compared to that of the 3rd quintile. A fully adjusted cubic spline model depicted a non-linear, J-shaped association between non-HDL-C and the risk of a composite CV event. The association remained robust in a series of sensitivity analyses, including the analysis of a cause-specific hazard model. Subgroup analyses reveled that the association is not significantly altered by clinical conditions, including age, gender, body mass index, estimated glomerular filtration rate, and albuminuria. In conclusion, high serum non-HDL-C level increased the risk of adverse CV outcomes among the patients with ND-CKD. Further studies are warranted to define the optimal target range of non-HDL-C levels in this population.https://www.mdpi.com/2072-6643/14/18/3792cardiovascular eventscardiovascular riskchronic kidney diseasemortalitynon-high-density lipoprotein cholesterol
spellingShingle Sang Heon Suh
Tae Ryom Oh
Hong Sang Choi
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Kook-Hwan Oh
Seung Hyeok Han
Soo Wan Kim
Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
Nutrients
cardiovascular events
cardiovascular risk
chronic kidney disease
mortality
non-high-density lipoprotein cholesterol
title Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
title_full Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
title_fullStr Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
title_full_unstemmed Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
title_short Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study
title_sort non high density lipoprotein cholesterol and cardiovascular outcomes in chronic kidney disease results from know ckd study
topic cardiovascular events
cardiovascular risk
chronic kidney disease
mortality
non-high-density lipoprotein cholesterol
url https://www.mdpi.com/2072-6643/14/18/3792
work_keys_str_mv AT sangheonsuh nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT taeryomoh nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT hongsangchoi nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT changseongkim nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT eunhuibae nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT seongkwonma nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT kookhwanoh nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT seunghyeokhan nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy
AT soowankim nonhighdensitylipoproteincholesterolandcardiovascularoutcomesinchronickidneydiseaseresultsfromknowckdstudy